Apoptosis inhibitors for heart disease

Circulation. 2003 Dec 16;108(24):2954-6. doi: 10.1161/01.CIR.0000097188.26010.E8.
No abstract available

Publication types

  • Comment
  • Editorial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Apoptosis*
  • Cardiac Output, Low / drug therapy
  • Cardiac Output, Low / etiology
  • Cardiac Output, Low / pathology
  • Cardiomegaly / etiology
  • Cardiomyopathy, Dilated / drug therapy
  • Cardiomyopathy, Dilated / pathology
  • Caspase Inhibitors*
  • Cysteine Proteinase Inhibitors / therapeutic use*
  • Disease Progression
  • Female
  • GTP-Binding Protein alpha Subunits, Gq-G11 / genetics
  • GTP-Binding Protein alpha Subunits, Gq-G11 / physiology
  • Heart Diseases / drug therapy*
  • Heart Diseases / pathology
  • Humans
  • Indoles / therapeutic use
  • Mice
  • Mice, Transgenic
  • Mitochondria / physiology
  • Oligopeptides / therapeutic use
  • Pregnancy

Substances

  • Caspase Inhibitors
  • Cysteine Proteinase Inhibitors
  • Indoles
  • N-((1,3-dimethylindole-2-carbonyl)-valinyl)-3-amino-4-oxo-5-fluoropentanoic acid
  • Oligopeptides
  • GTP-Binding Protein alpha Subunits, Gq-G11